{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:21:09Z","timestamp":1779103269482,"version":"3.51.4"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Overdoses caused by synthetic mu-opioid receptor (MOR) agonists such as fentanyl are causing increasing mortality in the United States. The COVID-19 pandemic continues to have complex effects on public health, including opioid use disorders (OUD). It is unclear whether recent increases in mortality caused by synthetic opioids have reached a plateau (i.e., a stable period), after the onset of the COVID-19 pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>This study examined provisional overdose mortality data from the Centers for Disease Control and Prevention, for synthetic opioids excluding methadone (code T40.4; monthly data available from 39 States, plus New York City and Washington DC), for June 2019\u2013November 2021. Data were first examined as crude mortality rates. The presence of a maximum plateau was analyzed for the last 4 months of available data. For authorities in which a plateau in mortality was detected, sigmoidal Boltzmann equations were used to model parameters of this phenomenon (e.g., level of the plateau).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At the end of the study period, all but one authority (New Hampshire) reported increases in mortality rates for synthetic opioids, compared to the baseline month of June 2019 (range: 111\u2013745% of baseline). A plateau was observed over the last 4 months of the study period (Aug 2021\u2013Nov 2021) in 29 of the authorities. Ten other authorities had not reached a stable plateau at the end of the study period. For the authorities where a plateau was detected, a sigmoidal Boltzmann model revealed a fitted maximum of 262% rise in mortality over the study period, from the baseline month. The midpoint in the rise in mortality was fitted in September 2020. After separation of data into census regions, the highest plateau was observed in the West region, followed by South, Midwest, and Northeast (fitted plateau values were 409, 262, 204, and 149% of baseline, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>There were increases in overdose mortality due to synthetic opioids across most states, ranging considerably in magnitude. A plateau in overdose mortality was detected at the end of the study period in most of these authorities. The reasons for these plateaus should be explored, in order to develop optimized public health interventions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2022.947603","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:27:28Z","timestamp":1657171648000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention Data to November 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Kate G.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly J.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo R.","family":"Butelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","author":"Kates","year":"2020","journal-title":"Stay-At-Home Orders to Fight COVID-19 in the United States: The Risks of a Scattershot Approach."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.","volume":"26","author":"Wang","year":"2020","journal-title":"Mol Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108590","article-title":"Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year.","volume":"133","author":"Bart","year":"2022","journal-title":"J Subst Abuse Treat."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108196","article-title":"Medication treatment for opioid use disorder in the age of COVID-19: can new regulations modify the opioid cascade?","volume":"122","author":"Nunes","year":"2021","journal-title":"J Subst Abuse Treat."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108977","article-title":"The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic.","volume":"228","author":"Root","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/aln.0000000000003848","article-title":"Functional profile of systemic and intrathecal cebranopadol in nonhuman primates.","volume":"135","author":"Ding","year":"2021","journal-title":"Anesthesiology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/cpt.2098","article-title":"Countermeasures for preventing and treating opioid overdose.","volume":"109","author":"France","year":"2020","journal-title":"Clin Pharmacol Ther."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022134118","article-title":"Neural basis of opioid-induced respiratory depression and its rescue.","volume":"118","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00000542-199207000-00022","article-title":"Elucidation of dose-effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat.","volume":"77","author":"Yang","year":"1992","journal-title":"Anesthesiology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00213-022-06125-5","article-title":"Treatment of opioid overdose: current approaches and recent advances.","volume":"239","author":"Britch","year":"2022","journal-title":"Psychopharmacology (Berl)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment.","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci Biobehav Rev."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16020177","article-title":"Non-medical use of novel synthetic opioids: a new challenge to public health.","volume":"16","author":"Lovrecic","year":"2019","journal-title":"Int J Environ Res Public Health."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00046","article-title":"Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems.","volume":"10","author":"Schifano","year":"2019","journal-title":"Front Pharmacol."},{"key":"B14","year":"2020","journal-title":"Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2014 United States, 2000\u20132014.","volume":"64","author":"Rudd","year":"2015","journal-title":"Morb Mortal Wkly Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2105\/ajph.2017.304265","article-title":"Quantifying the epidemic of prescription opioid overdose deaths.","volume":"108","author":"Seth","year":"2018","journal-title":"Am J Public Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis.","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy."},{"key":"B18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drugalcdep.2017.04.004","article-title":"Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids.","volume":"177","author":"Cicero","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1037\/tra0000660","article-title":"COVID-19, mental health, and opioid use disorder: old and new public health crises intertwine.","volume":"12","author":"Henry","year":"2020","journal-title":"Psychol Trauma."},{"key":"B20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jamapsychiatry.2020.4148","article-title":"The hidden epidemic of opioid overdoses during the coronavirus disease 2019 pandemic.","volume":"78","author":"Kosten","year":"2021","journal-title":"JAMA Psychiatry."},{"key":"B21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7326\/m20-1212","article-title":"Collision of the COVID-19 and addiction epidemics.","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41591-020-0898-0","article-title":"An overdose surge will compound the COVID-19 pandemic if urgent action is not taken.","volume":"26","author":"Wakeman","year":"2020","journal-title":"Nat Med."},{"key":"B23","author":"Ahmad","year":"2021","journal-title":"Provisional Drug Overdose Death Counts."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108019","article-title":"Treatment of overdose in the synthetic opioid era.","volume":"233","author":"Skolnick","year":"2021","journal-title":"Pharmacol Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/07853890.2022.2067350","article-title":"Opioid overdose decedent characteristics during COVID-19.","volume":"54","author":"Garcia","year":"2022","journal-title":"Ann Med."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263893","article-title":"Nonfatal opioid overdoses before and after Covid-19: regional variation in rates of change.","volume":"17","author":"Burgess-Hull","year":"2022","journal-title":"PLoS One."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100218","article-title":"Impact of the COVID-19 pandemic on temporal patterns of mental health and substance abuse related mortality in Michigan: an interrupted time series analysis.","volume":"10","author":"Larson","year":"2022","journal-title":"Lancet Reg Health Am."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25538","article-title":"Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island.","volume":"4","author":"Macmadu","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ajad.13148","article-title":"Brief report: the impact of COVID-19 on emergency department overdose diagnoses and county overdose deaths.","volume":"30","author":"Shreffler","year":"2021","journal-title":"Am J Addict."},{"key":"B30","author":"Fontaine","year":"2019","journal-title":"Describing Epidemiologic Data."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97077-x","article-title":"Plateaus, rebounds and the effects of individual behaviours in epidemics.","volume":"11","author":"Berestycki","year":"2021","journal-title":"Sci Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"40400","DOI":"10.1007\/s11356-020-11188-y","article-title":"Mathematical model of Boltzmann\u2019s sigmoidal equation applicable to the spreading of the coronavirus (Covid-19) waves.","volume":"28","author":"El Aferni","year":"2021","journal-title":"Environ Sci Pollut Res Int."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30248-5","article-title":"Sigmoidal acquisition curves are good indicators of conformist transmission.","volume":"8","author":"Smaldino","year":"2018","journal-title":"Sci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"32764","DOI":"10.1073\/pnas.2009911117","article-title":"Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.","volume":"117","author":"Weitz","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/003335491513000411","article-title":"Drug overdose deaths: let\u2019s get specific.","volume":"130","author":"Slavova","year":"2015","journal-title":"Public Health Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.23907\/2013.029","article-title":"State variation in certifying manner of death and drugs involved in drug intoxication deaths.","volume":"3","author":"Warner","year":"2013","journal-title":"Acad Forensic Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/pd.4833","article-title":"The maternal age-related first trimester risks for trisomy 21, 18 and 13 based on Danish first trimester data from 2005 to 2014.","volume":"36","author":"Hartwig","year":"2016","journal-title":"Prenatal Diagnosis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/aln.0000000000002991","article-title":"Analgesic and respiratory depressant effects of R-dihydroetorphine: a pharmacokinetic-pharmacodynamic analysis in healthy male volunteers.","volume":"131","author":"Olofsen","year":"2019","journal-title":"Anesthesiology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","article-title":"Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic.","volume":"46","author":"Fairbairn","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/jamapsychiatry.2020.4402","article-title":"Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic.","volume":"78","author":"Holland","year":"2021","journal-title":"JAMA Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/yco.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"106845","DOI":"10.1016\/j.ypmed.2021.106845","article-title":"Growing racial\/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California.","volume":"153","author":"Friedman","year":"2021","journal-title":"Prev Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamapsychiatry.2022.0004","article-title":"Evaluation of Increases in drug overdose mortality rates in the us by race and ethnicity before and during the COVID-19 pandemic.","volume":"79","author":"Friedman","year":"2022","journal-title":"JAMA Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41591-020-0855-y","article-title":"Age and generational patterns of overdose death risk from opioids and other drugs.","volume":"26","author":"Jalal","year":"2020","journal-title":"Nat Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/add.15942","article-title":"Rapid changes in illegally manufactured fentanyl products and prices in the United States.","author":"Kilmer","year":"2022","journal-title":"Addiction."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108314","article-title":"Steep increases in fentanyl-related mortality west of the Mississippi River: recent evidence from county and state surveillance.","volume":"216","author":"Shover","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"B47","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyls in the opioid street market: desired or imposed?","volume":"114","author":"Mars","year":"2018","journal-title":"Addiction."},{"key":"B48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","article-title":"Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically.","volume":"68","author":"Macmadu","year":"2017","journal-title":"Addict Behav."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data.","volume":"214","author":"Slavova","year":"2020","journal-title":"Drug and Alcohol Depend."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/add.15260","article-title":"Carfentanil and the rise and fall of overdose deaths in the United States.","volume":"116","author":"Jalal","year":"2021","journal-title":"Addiction."},{"key":"B51","author":"Spencer","year":"2016","journal-title":"Timeliness of Death Certificate Data for Mortality Surveillance and Provisional Estimates."},{"key":"B52","year":"2020","journal-title":"Provisional Drug Overdose Death Counts."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19042230","article-title":"The Impact of the COVID-19 pandemic on drug use behaviors, fentanyl exposure, and harm reduction service support among people who use drugs in rural settings.","volume":"19","author":"Bolinski","year":"2022","journal-title":"Int J Environ Res Public Health."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.947603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:27:33Z","timestamp":1657171653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.947603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":53,"alternative-id":["10.3389\/fpsyt.2022.947603"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.947603","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"947603"}}